O
TNDM icon

OppenheimerFunds’s Tandem Diabetes Care TNDM Stock Holding History

OppenheimerFunds’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,554
Closed -$232K – 1833
2018
Q2 		$232K Sell
10,554
-274
-3% -$3.37K ﹤0.01% 1718
2018
Q1 		$54K Buy
+10,828
New +$34.9K ﹤0.01% 1769

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

OppenheimerFunds's TNDM Position: Q3 2018 in Review

OppenheimerFunds sold out of Tandem Diabetes Care (TNDM) in Q3 2018, closing a stake of 10,554 shares — an estimated $232K sold.

OppenheimerFunds first reported a position in TNDM in Q1 2018 and held it in 2 quarters. The position peaked at $232K in Q2 2018. 184 funds tracked by Wall St. Rank hold TNDM as of Q3 2018.

  • OppenheimerFunds reported no remaining Tandem Diabetes Care position as of Q3 2018 after selling out during the quarter.
  • OppenheimerFunds sold 10,554 Tandem Diabetes Care shares in Q3 2018, an estimated $232K.
  • OppenheimerFunds first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 2 quarters.
  • OppenheimerFunds's Tandem Diabetes Care position peaked at $232K in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2018.

Based on OppenheimerFunds's 13F filing for Q3 2018, filed 13 Nov 2018.